The use of hematopoietic growth factors to support cytotoxic chemotherapy for patients with breast cancer.
The rationale for the uses of hematopoietic growth factors in the treatment of breast cancer is reviewed. The historical background of development of these novel therapeutic agents is also summarized as it pertains to patients undergoing myelosuppressive treatments. Important areas of controversy in the clinical uses of hematopoietic growth factors are identified, and future research directions in this field are discussed.